AI language models cannot honestly think, react or create, despite widespread hype. Recent failed trials of late-stage heart drugs by Novartis and Novo Nordisk, claiming AI-driven research created costly disappointments. With these failures, skepticism is directed towards pharmaceutical promises, artificial intelligence "superintelligence" and technology-driven medical breakthroughs.